Quantcast

Latest AstraZeneca Stories

2014-03-19 04:20:42

BASEL, Switzerland, March 19, 2014 /PRNewswire/ -- Syngenta today announced that its 2013 Annual Report is now available at www.syngenta.com/ar2013. The 2013 Annual Report consists of the following documents: -- Annual Review, incorporating the Corporate Responsibility Report -- Financial Report -- Corporate Governance and Compensation Report All documents are in English and German except for the Financial Report, which is published in English only. Printed copies of these...

2014-03-16 16:20:46

CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust Sanger Institute, announced today the publication in Nature Biotechnology of a paper describing its breakthrough therapeutic antibody discovery technology, Kymouse(TM) (http://dx.doi.org). Scientists at Kymab have engineered a mouse with the full set of genes encoding the human antibody repertoire, calling this...

2014-03-12 08:29:43

BEIJING, March 12, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014 EDT. The Company will host a conference call prior to the market opening on Thursday, March 20, 2014, at 8:00 a.m. EDT (Thursday, March 20, 2014 at 8:00 p.m. China Standard...

2014-03-06 08:31:20

CAMBRIDGE, Mass., March 6, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today that Lorence Kim, M.D. will join Moderna's executive leadership team as chief financial officer effective April 21. Prior to joining Moderna, Dr. Kim was managing director and co-head of the U.S. biotechnology investment banking effort at...

2014-03-05 23:30:09

Dr. Dominick Angiolillo begins clinical study of rapid CYP2C19 genotyping in Jacksonville. Ottawa, Ontario (PRWEB) March 05, 2014 Spartan Bioscience today announced the start of a study of personalized medicine at the University of Florida. The Spartan RX CYP2C19 System is being used to test heart attack patients receiving cardiac stents. The study is entitled “A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function...

2014-03-03 00:20:29

BASEL, Switzerland, March 3, 2014 /PRNewswire/ -- -- ELATUS((TM)) fungicide receives regulatory approval in Brazil -- Delivers outstanding control of soybean rust disease -- Higher and more predictable yields for Latin American growers Syngenta today announced that ELATUS, a breakthrough foliar fungicide, has been approved by the Brazilian authorities. ELATUS is a combination of Syngenta's new SDHI chemistry SOLATENOL((TM) )and AMISTAR(®). It offers unrivaled performance...

2014-02-25 20:21:36

DUBLIN, February 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines) has announced the addition of the "H1N1 Vaccines - Global Strategic Business Report" [http://www.researchandmarkets.com/research/jnwqq6/h1n1_vaccines ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides...

2014-02-20 16:21:25

Agreement with Biopharmaceutical Leader is Indicative of the Longstanding Value of CAS Products COLUMBUS, Ohio, Feb. 20, 2014 /PRNewswire/ -- Chemical Abstracts Service (CAS), the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder(®), the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The...

2014-02-20 12:23:17

- Agrisure Duracade(TM) introductory launch program "Right to Grow" offers farmers step-change in corn rootworm control and 2014 grain marketing options MINNETONKA, Minn., Feb. 20, 2014 /PRNewswire/ -- Syngenta announced today an agreement with Gavilon Grain, LLC that provides grain marketing opportunities for farmers who choose to plant Agrisure Duracade, the cutting-edge corn rootworm (CRW) control technology that has been approved in the U.S. For farmers participating in the...

2014-02-20 08:32:38

COLUMBIA, S.C., Feb. 20, 2014 /PRNewswire/ -- BDI Pharma today announced the launch of The MERREM Commitment Program(TM) with AstraZeneca, an assurance initiative offering customers security in product availability through contracted access to the original, branded MERREM®I.V. from AstraZeneca. Along with this innovative new partnership, BDI Pharma was awarded the status of Authorized Distributor of Record (ADR) for AstraZeneca and is the sole and exclusive distributor of...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'